Go Pro
NASDAQ:BRBI

BR Biopharma Q1 2026 Earnings Report

BR Biopharma logo
$11.72 +0.49 (+4.31%)
As of 03:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BR Biopharma EPS Results

Actual EPS
$0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BR Biopharma Revenue Results

Actual Revenue
$25.95 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BR Biopharma Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

BR Biopharma Earnings Headlines

Contrasting BR Biopharma (BRBI) & Its Rivals
Financial Survey: BR Biopharma (BRBI) & The Competition
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he says is the same size Nvidia was a decade ago. The company holds 150 patents protecting its core technology, and Brown believes Elon Musk could soon drive major demand for it. A key catalyst is set for November 11.tc pixel
BR Biopharma (BRBI) & Its Rivals Head-To-Head Comparison
See More BR Biopharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BR Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BR Biopharma and other key companies, straight to your email.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.

View BR Biopharma Profile